Novo Nordisk's first-ever ad for its new FDA-approved GLP-1 pill will air during Sunday's (Feb. 8) big game.

Independent of FDA’s enhanced oversight, it’s clear that DTC promotion of weight loss drugs is having a moment, as companies go all in in pursuit of uptake expansion.

With pill fatigue on the rise and modern diets falling short, wellness editor Emilie Lavinia tests whether a holistic liquid ...

Add Yahoo as a preferred source to see more of our stories on Google. DJ Khaled wants to shout from the rooftops about the benefits of the new Wegovy pill. The “We The Best” rapper/producer is one of ...

Social media users have been warned they risk breaking the law by promoting weight-loss jabs, after posts by members of the public endorsing the injections were banned by the advertising regulator for ...

The new Wegovy is for people who never thought they would use a GLP-1 — whether they just had a baby or are going into ...

The Super Bowl has long acted as one of the biggest events for ads, and Super Bowl LX was no different. With Sunday’s game setting a record for peak viewership with 137.8 million tuning in during the ...

Scientists are testing an entirely new way to fight heart disease: whether gene editing might offer a one-time fix for high ...

It’s estimated that about one in 10 Americans have taken a GLP‑1 weight‑loss drug, and demand is surging. Ads are everywhere, but so are concerns about safety, cost and ...

Serena Williams reveals losing 15 kg using a GLP-1 drug after pregnancy in a Super Bowl 2026 ad, sparking debate on celebrity endorsements and weight-loss medicines ...